ILLUMINATE RX Trademark

Trademark Overview

On Monday, February 3, 2025, a trademark application was filed for ILLUMINATE RX with the United States Patent and Trademark Office. The USPTO has given the ILLUMINATE RX trademark a serial number of 99026964. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, July 31, 2025. This trademark is owned by Illuminate Rx, Inc.. The ILLUMINATE RX trademark is filed in the Insurance & Financial Services category with the following description:

Pharmacy benefit management services
illuminate rx

General Information

Serial Number99026964
Word MarkILLUMINATE RX
Filing DateMonday, February 3, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, July 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmacy benefit management services
NOT AVAILABLE"RX"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, February 3, 2025
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIlluminate Rx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35243

Trademark Events

Event DateEvent Description
Monday, February 3, 2025NEW APPLICATION ENTERED
Monday, February 3, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 14, 2025ASSIGNED TO EXAMINER
Friday, July 18, 2025NON-FINAL ACTION E-MAILED
Friday, July 18, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 18, 2025NON-FINAL ACTION WRITTEN
Thursday, July 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

illuminate services management benefit pharmacy